Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Second Avenue Partners
AddedFeb 13, 2024
UpdatedJul 22, 2026
Second Avenue Partners

Second Avenue Partners

Operating

Second Avenue Partners: A venture capital firm offering management, strategy, and capital for startups.

Location
Seattle, WA, US
Founded
2000
Firm
Compare
Portfolio
Employees
Website

Investments

FitOn
FitOn

Total Raised

$70M

Rounds

6

Series B$40MDecember 2021
Series B$18MOctober 2021
Knack
Knack

Total Raised

$10M

Rounds

2

Series A$3.5MNovember 2021
Seeq
Seeq

Total Raised

$115.2M

Rounds

7

Series C$50MApril 2021
Series B$5.8MSeptember 2020
Series B$23MJuly 2018
Series A$6MNovember 2013
R.P. Home & Harvest
R.P. Home & Harvest

Total Raised

$60M

Rounds

1

Debt Financing$60MJune 2020
Modumetal
Modumetal

Total Raised

$101M

Rounds

13

Series Unknown$14MJanuary 2019
Series Unknown$33.5MAugust 2015
Series Unknown$10MNovember 2012
Series Unknown$3.5MMay 2009
RealSelf
RealSelf

Total Raised

$42M

Rounds

4

Series CAugust 2018
Tommie Copper
Tommie Copper

Total Raised

$14M

Rounds

5

Debt FinancingMay 2018
Iunu
Iunu

Total Raised

$45.7M

Rounds

8

Series A$6MSeptember 2017
Migo
Migo

Total Raised

$11.1M

Rounds

3

Seed$1.8MFebruary 2017
Industrial Generosity
Industrial Generosity
Acquired

Total Raised

$750k

Rounds

2

Seed$325kOctober 2014
Seed$425kMay 2014
Lively
Lively

Total Raised

$2.8M

Rounds

4

Series Unknown$1.9MJanuary 2014
Flexe
Flexe

Total Raised

$263M

Rounds

7

Seed$6.5MSeptember 2013
TreeRing
TreeRing

Total Raised

$7.6M

Rounds

3

Series A$3.6MSeptember 2012
JeNu Biosciences
JeNu Biosciences

Total Raised

$4.9M

Rounds

4

Seed$3MJanuary 2012
Inkd.com
Inkd.com

Total Raised

$5.6M

Rounds

3

Series B$3.5MJune 2011
Series A$1.7MSeptember 2008
Qliance Medical Management
Qliance Medical Management

Total Raised

$27.3M

Rounds

7

Series B$6MApril 2010